TickerFactsScreenerDevelopers

Corvus Pharmaceuticals, Inc. (CRVS) — Operating Income

Annual figures by fiscal year, from SEC filings.

2015: -$13.77M2016: -$36.98M2017: -$56.52M2018: -$49.22M2019: -$48.85M2020: -$43.76M2021: -$38.63M2022: -$32.56M2023: -$23.41M2024: -$27.55M2025: -$42.97M-$42.97M
2015Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$42.97M-56.0%
2024-$27.55M-17.7%
2023-$23.41M+28.1%
2022-$32.56M+15.7%
2021-$38.63M+11.7%
2020-$43.76M+10.4%
2019-$48.85M+0.7%
2018-$49.22M+12.9%
2017-$56.52M-52.9%
2016-$36.98M-168.5%
2015-$13.77M—